Skip to main content
Contact Us
Subscribe
E-Edition
40°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
8
Next >
Down 88%, Could Editas Medicine Be a Good Investment Now?
January 15, 2024
Tickers
CRSP
EDIT
VRTX
Tags
VRTX
CRSP
Recent Press Releases
From
Motley Fool
3 Stocks to Buy in the Booming Field of Gene Editing
January 11, 2024
Tickers
BEAM
EDIT
LLY
VERV
Tags
Market News
NASDAQ:EDIT,NASDAQ:VRTX,NASDAQ:BEAM,NASDAQ:VERV,NYSE:LLY
BEAM
From
InvestorPlace
Better Gene-Editing Stock: Editas Medicine vs. Intellia Therapeutics
January 08, 2024
Tickers
EDIT
NTLA
Tags
NTLA
Recent Press Releases
Market News
From
Motley Fool
Editas Just Caught a Break Thanks to Vertex Pharmaceuticals
December 23, 2023
Tickers
EDIT
VRTX
Tags
EDIT
Recent Press Releases
Market News
From
Motley Fool
Vertex’s stock heads for all-time high as non-opioid painkiller shows promise
December 13, 2023
Tickers
EDIT
SPX
VRTX
VTRS
Tags
SPX
VRTX
VTRS
From
MarketWatch
The Latest Analyst Ratings for Editas Medicine
December 12, 2023
Tickers
EDIT
Tags
EDIT
BZI/AAR
Analyst Ratings
From
Benzinga
Crispr Therapeutics, Vertex get FDA approval for breakthrough gene-editing treatment
December 08, 2023
Tickers
BLUE
CRSP
EDIT
VRTX
Tags
EDIT
BLUE
CRSP
From
MarketWatch
1 Promising Stock Down 66% That Could Skyrocket in 2024
December 05, 2023
Tickers
EDIT
Tags
Recent Press Releases
Market News
EDIT
From
Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
Tickers
ARKG
BEAM
CRBU
CRSP
Tags
NTLA
Recent Press Releases
LLY
From
Motley Fool
If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 Names
November 29, 2023
Tickers
BLUE
EDIT
GPCR
Tags
EDIT
NASDAQ:EDIT,NASDAQ:BLUE,NASDAQ:GPCR
Stocks to Buy
From
InvestorPlace
Hidden Gems for Hefty Returns: 3 Stocks Set to Double Your Wealth Next Year
November 22, 2023
Tickers
AMD
EDIT
MARA
Tags
NASDAQ:AMD,NASDAQ:MARA,NASDAQ:EDIT
MARA
EDIT
From
InvestorPlace
The 3 Best Gene Editing Stocks on the Frontier of Medicine
November 20, 2023
Tickers
ARKG
BEAM
EDIT
Tags
BEAM
Market News
EDIT
From
InvestorPlace
2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall Street
November 20, 2023
Tickers
AAPL
BLUE
CRSP
EDIT
Tags
VRTX
CRSP
GOOGL
From
Motley Fool
3 Long-Term Growth Stocks Analysts Are Bullish On
November 16, 2023
Tickers
CRSP
EDIT
NVDA
SQ
Tags
EDIT
Stocks to Buy
SQ
From
InvestorPlace
3 Biotech Stocks That Are Betting on the Future of Gene Editing
November 09, 2023
Tickers
CRSP
EDIT
NTLA
REGN
Tags
Market News
NASDAQ:CRSP,NASDAQ:VRTX,NASDAQ:EDIT,NASDAQ:NTLA,NASDAQ:REGN
REGN
From
InvestorPlace
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 03, 2023
Tickers
AGL
ALLO
AMCX
ATGL
Tags
QRTEA
News
Mid/Day Movers
From
Benzinga
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
November 03, 2023
Tickers
ALLO
AMCX
AXL
CAH
Tags
MGA
RGEN
FIVN
From
Benzinga
Earnings Scheduled For November 3, 2023
November 03, 2023
Tickers
ACRE
AMCX
ARQT
ASIX
Tags
Benzinga
WPC
EAF
From
Benzinga
A Preview Of Editas Medicine's Earnings
November 02, 2023
Tickers
EDIT
Tags
EDIT
BZI/EP
Earnings
From
Benzinga
Sent Your Boss The Message Meant For Your Girlfriend On Instagram — Now You Can Save Your Bacon
November 01, 2023
Tickers
EDIT
META
TECH
X
Tags
Consumer Tech
Benzinga
edit
From
Benzinga
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
October 30, 2023
Tickers
AMGN
BLUE
CRSP
EDIT
Tags
EDIT
REGN
CRSP
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
Tickers
ABNB
ALKS
AMZN
ANL
Tags
HR
Analyst Ratings
MEDP
From
Benzinga
3 Gene Editing Stocks to Generate Super-Charged Gains
October 18, 2023
Tickers
BEAM
CRSP
EDIT
GNOM
Tags
GNOM
Market News
BEAM
From
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023
October 18, 2023
Tickers
ALB
ALPN
ARM
BIP
Tags
SBSW
Benzinga
EVLO
From
Benzinga
1 Risky Biotech Stock to Consider Buying, and 1 to Avoid
October 18, 2023
Tickers
BEAM
EDIT
Tags
Recent Press Releases
Market News
BEAM
From
Motley Fool
Analyst Ratings for Editas Medicine
October 18, 2023
Tickers
EDIT
Tags
Market News
Benzinga
Analyst Ratings
From
Benzinga
Editas Medicine Has To Navigate Sickle Cell Therapy Competition: Analyst
October 17, 2023
Tickers
BLUE
CRSP
EDIT
Tags
Small Cap
General
Biotech
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
Tickers
ACA
ACAD
ACDC
ACLX
Tags
ACLX
FCX
ARRY
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 17, 2023
Tickers
AHG
AMAM
ARDX
EDIT
Tags
SPWR
VSAT
TPST
From
InvestorPlace
NetScout Systems, Ericsson And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
October 17, 2023
Tickers
AMAM
EDIT
ERIC
NOK
Tags
Benzinga
Movers
big losers
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.